AGWCA
TMO icon

Annis Gardner Whiting Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Annis Gardner Whiting Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$410K Buy
817
+38
+5% +$18.2K 0.06% 230
2026
Q1 		$383K Sell
779
-21
-3% -$11.4K 0.06% 219
2025
Q4 		$464K Buy
800
+42
+6% +$23.8K 0.09% 187
2025
Q3 		$368K Sell
758
-108
-12% -$50.3K 0.08% 207
2025
Q2 		$351K Buy
866
+44
+5% +$18.4K 0.12% 151
2025
Q1 		$409K Sell
822
-57
-6% -$30.9K 0.17% 118
2024
Q4 		$458K Sell
879
-12
-1% -$6.6K 0.13% 138
2024
Q3 		$551K Sell
891
-230
-21% -$136K 0.16% 117
2024
Q2 		$620K Buy
1,121
+12
+1% +$6.88K 0.18% 107
2024
Q1 		$645K Buy
1,109
+310
+39% +$174K 0.23% 83
2023
Q4 		$424K Sell
799
-20
-2% -$9.68K 0.19% 100
2023
Q3 		$415K Buy
+819
New +$436K 0.22% 87

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Annis Gardner Whiting Capital Advisors's TMO Position: Q2 2026 in Review

Annis Gardner Whiting Capital Advisors increased its Thermo Fisher Scientific (TMO) stake by 4.9% in Q2 2026, buying an estimated $18.2K and bringing the position to 817 shares worth $410K. The position accounts for 0.06% of the portfolio, ranked #230.

Annis Gardner Whiting Capital Advisors first reported a position in TMO in Q3 2023 and has held it in 12 quarters since. The position peaked at $645K in Q1 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Annis Gardner Whiting Capital Advisors held 817 shares of Thermo Fisher Scientific worth $410K as of Q2 2026.
  • Annis Gardner Whiting Capital Advisors bought 38 Thermo Fisher Scientific shares in Q2 2026, an estimated $18.2K.
  • Thermo Fisher Scientific made up 0.06% of Annis Gardner Whiting Capital Advisors's portfolio in Q2 2026, its #230 holding.
  • Annis Gardner Whiting Capital Advisors first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 12 quarters since.
  • Annis Gardner Whiting Capital Advisors's Thermo Fisher Scientific position peaked at $645K in Q1 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.